+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Migraine Drugs Market Research Report by Therapeutic Class, Treatment Type, Route of Administration, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 233 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968814
UP TO OFF until Dec 31st 2022
The Global Migraine Drugs Market size was estimated at USD 3,546.06 million in 2021, USD 4,097.67 million in 2022, and is projected to grow at a CAGR 15.73% to reach USD 8,520.87 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Migraine Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Therapeutic Class, the market was studied across Anti-Nausea Drug, Blood Pressure Lowering Medication, Ergots, Opioid Medication, Pain Reliever, and Triptans. The Anti-Nausea Drug is further studied across Chlorpromazine, Metoclopramide, and Prochlorperazine. The Blood Pressure Lowering Medication is further studied across Beta-Blocker and Calcium Channel Blocker. The Ergots is further studied across Dihydroergotamines, Ergotamine, and Lasmiditan. The Opioid Medication is further studied across OxyContin, Percocet, and Vicodin. The Pain Reliever is further studied across Aspirin and Ibuprofen. The Triptans is further studied across Rizatriptan and Sumatriptan.
  • Based on Treatment Type, the market was studied across Abortive and Preventive.
  • Based on Route of Administration, the market was studied across Injectable, Nasal Spray, and Oral.
  • Based on Distribution, the market was studied across Hospitals Based Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Migraine Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Migraine Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Migraine Drugs Market, including Aegis Therapeutics, Alder Biopharmaceuticals, Allergan, Eli Lilly, GlaxoSmithKline, Impax Laboratories, Johnson & Johnson, Luitpold Pharmaceuticals, Pfizer, TG Therapeutics, and Winston Pharmaceuticals.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Migraine Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Migraine Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Migraine Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Migraine Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Migraine Drugs Market?
6. What is the market share of the leading vendors in the Global Migraine Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Migraine Drugs Market?
Frequently Asked Questions about the Global Migraine Drugs Market

What is the estimated value of the Global Migraine Drugs Market?

The Global Migraine Drugs Market was estimated to be valued at $3546.06 Million in 2021.

What is the growth rate of the Global Migraine Drugs Market?

The growth rate of the Global Migraine Drugs Market is 15.7%, with an estimated value of $8520.87 Million by 2027.

What is the forecasted size of the Global Migraine Drugs Market?

The Global Migraine Drugs Market is estimated to be worth $8520.87 Million by 2027.

Who are the key companies in the Global Migraine Drugs Market?

Key companies in the Global Migraine Drugs Market include Aegis Therapeutics, Alder Biopharmaceuticals, Allergan, Eli Lilly, GlaxoSmithKline, Impax Laboratories, Johnson & Johnson, Luitpold Pharmaceuticals and TG Therapeutics.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of migraines and launch of new drugs
5.1.1.2. Rise in female population and increase in cigarette consumption
5.1.1.3. Advancements in healthcare facilities such as electrical nerve stimulation devices
5.1.2. Restraints
5.1.2.1. Side effects associated with migraine drugs
5.1.3. Opportunities
5.1.3.1. Supportive reimbursement policies for migraine medications
5.1.3.2. Increased programmes of collaboration and partnership in the pharmaceutical sector
5.1.4. Challenges
5.1.4.1. Availability of alternative therapies and regulatory challenges
5.2. Cumulative Impact of COVID-19
6. Migraine Drugs Market, by Therapeutic Class
6.1. Introduction
6.2. Anti-Nausea Drug
6.2.1. Chlorpromazine
6.2.2. Metoclopramide
6.2.3. Prochlorperazine
6.3. Blood Pressure Lowering Medication
6.3.1. Beta-Blocker
6.3.2. Calcium Channel Blocker
6.4. Ergots
6.4.1. Dihydroergotamines
6.4.2. Ergotamine
6.4.3. Lasmiditan
6.5. Opioid Medication
6.5.1. OxyContin
6.5.2. Percocet
6.5.3. Vicodin
6.6. Pain Reliever
6.6.1. Aspirin
6.6.2. Ibuprofen
6.7. Triptans
6.7.1. Rizatriptan
6.7.2. Sumatriptan
7. Migraine Drugs Market, by Treatment Type
7.1. Introduction
7.2. Abortive
7.3. Preventive
8. Migraine Drugs Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Nasal Spray
8.4. Oral
9. Migraine Drugs Market, by Distribution
9.1. Introduction
9.2. Hospitals Based Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Americas Migraine Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Migraine Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Migraine Drugs Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Aegis Therapeutics
14.2. Alder Biopharmaceuticals
14.3. Allergan
14.4. Eli Lilly
14.5. GlaxoSmithKline
14.6. Impax Laboratories
14.7. Johnson & Johnson
14.8. Luitpold Pharmaceuticals
14.9. Pfizer
14.10. TG Therapeutics
14.11. Winston Pharmaceuticals
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL MIGRAINE DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL MIGRAINE DRUGS MARKET DYNAMICS
FIGURE 8. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2021 VS 2027 (%)
FIGURE 9. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2027
FIGURE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 53. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 54. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2027
FIGURE 56. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 61. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 63. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, 2019-2027 (USD MILLION)
FIGURE 64. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 65. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 67. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 68. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 69. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 70. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 72. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, 2019-2027 (USD MILLION)
FIGURE 73. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 74. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 75. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 76. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 77. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 78. AMERICAS MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 80. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 82. ARGENTINA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. BRAZIL MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. CANADA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. MEXICO MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. UNITED STATES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 88. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 89. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY STATE, 2027
FIGURE 90. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 92. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 93. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 94. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. CHINA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 96. INDIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 97. INDONESIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. JAPAN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. MALAYSIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. SINGAPORE MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. TAIWAN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. THAILAND MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 107. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 108. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 109. FRANCE MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 110. GERMANY MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 111. ITALY MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 112. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 113. QATAR MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 114. RUSSIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 115. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 116. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 117. SPAIN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 118. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 119. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 120. GLOBAL MIGRAINE DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 121. GLOBAL MIGRAINE DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 122. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MIGRAINE DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL MIGRAINE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ANTI-NAUSEA DRUG, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY CHLORPROMAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY METOCLOPRAMIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY PROCHLORPERAZINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY BLOOD PRESSURE LOWERING MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY BETA-BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ERGOTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY DIHYDROERGOTAMINES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ERGOTAMINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY LASMIDITAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 64. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY OPIOID MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY OXYCONTIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY PERCOCET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY VICODIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY PAIN RELIEVER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ASPIRIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY REGION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY STATE, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY IBUPROFEN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY REGION, 2019-2027 (USD MILLION)
TABLE 97. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY STATE, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY TRIPTANS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 102. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY RIZATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 107. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 109. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY SUMATRIPTAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY REGION, 2019-2027 (USD MILLION)
TABLE 113. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY STATE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ABORTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 123. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2019-2027 (USD MILLION)
TABLE 124. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY STATE, 2019-2027 (USD MILLION)
TABLE 126. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 128. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY REGION, 2019-2027 (USD MILLION)
TABLE 129. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY STATE, 2019-2027 (USD MILLION)
TABLE 131. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 133. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 134. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 136. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 138. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 139. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 140. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 141. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 142. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY HOSPITALS BASED PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 144. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 145. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 146. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 147. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 149. GLOBAL MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 150. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 151. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 152. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 154. AMERICAS MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 156. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 157. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 158. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 159. AMERICAS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 160. ARGENTINA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 161. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 162. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 163. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 164. ARGENTINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 165. BRAZIL MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 167. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 168. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 169. BRAZIL MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 170. CANADA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. CANADA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 172. CANADA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 173. CANADA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 174. CANADA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 175. MEXICO MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 176. MEXICO MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 177. MEXICO MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 178. MEXICO MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 179. MEXICO MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 180. UNITED STATES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 181. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 182. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 183. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 184. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 185. UNITED STATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 186. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 187. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 188. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 189. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 190. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 191. ASIA-PACIFIC MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 192. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 194. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 195. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 196. AUSTRALIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 197. CHINA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. CHINA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 199. CHINA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 200. CHINA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 201. CHINA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 202. INDIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 203. INDIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 204. INDIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 205. INDIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 206. INDIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 207. INDONESIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 208. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 209. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 210. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 211. INDONESIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 212. JAPAN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 213. JAPAN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 214. JAPAN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 215. JAPAN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 216. JAPAN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 217. MALAYSIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 218. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 219. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 220. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 221. MALAYSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 222. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 223. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 224. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 225. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 226. PHILIPPINES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 227. SINGAPORE MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 228. SINGAPORE MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 229. SINGAPORE MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 230. SINGAPORE MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 231. SINGAPORE MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 232. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 233. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 234. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 235. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 236. SOUTH KOREA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 237. TAIWAN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 238. TAIWAN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 239. TAIWAN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 240. TAIWAN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 241. TAIWAN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 242. THAILAND MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 243. THAILAND MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 244. THAILAND MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 245. THAILAND MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 246. THAILAND MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 253. FRANCE MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 254. FRANCE MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 255. FRANCE MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 256. FRANCE MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 257. FRANCE MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 258. GERMANY MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 259. GERMANY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 260. GERMANY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 261. GERMANY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 262. GERMANY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 263. ITALY MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. ITALY MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 265. ITALY MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 266. ITALY MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 267. ITALY MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 268. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 269. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 270. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 271. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 272. NETHERLANDS MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 273. QATAR MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 274. QATAR MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 275. QATAR MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 276. QATAR MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 277. QATAR MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 278. RUSSIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 279. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 280. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 281. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 282. RUSSIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 283. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 284. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 285. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 286. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 287. SAUDI ARABIA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 288. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 289. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 290. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 291. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 292. SOUTH AFRICA MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 293. SPAIN MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 294. SPAIN MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 295. SPAIN MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 296. SPAIN MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 297. SPAIN MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 303. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 304. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2019-2027 (USD MILLION)
TABLE 305. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD MILLION)
TABLE 306. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 307. UNITED KINGDOM MIGRAINE DRUGS MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 308. GLOBAL MIGRAINE DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 309. GLOBAL MIGRAINE DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 310. GLOBAL MIGRAINE DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 311. GLOBAL MIGRAINE DRUGS MARKET RANKING
TABLE 312. GLOBAL MIGRAINE DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 313. GLOBAL MIGRAINE DRUGS MARKET MERGER & ACQUISITION
TABLE 314. GLOBAL MIGRAINE DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 315. GLOBAL MIGRAINE DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 316. GLOBAL MIGRAINE DRUGS MARKET INVESTMENT & FUNDING
TABLE 317. GLOBAL MIGRAINE DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 318. GLOBAL MIGRAINE DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • Aegis Therapeutics
  • Alder Biopharmaceuticals
  • Allergan
  • Eli Lilly
  • GlaxoSmithKline
  • Impax Laboratories
  • Johnson & Johnson
  • Luitpold Pharmaceuticals
  • Pfizer
  • TG Therapeutics
  • Winston Pharmaceuticals

Methodology

Loading
LOADING...